- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03268460
Incidence of Renal Tubular Acidosis in Nephrology Unit in Assiut University Childern Hospital
Incidence of Renal Tubular Acidosis in Nephrology Unit in Assiut University Childern Hospital (AUCH)
Study Overview
Status
Conditions
Detailed Description
The term renal tubular acidosis (RTA) is applied to a group of transport defects in the reabsorption of bicarbonate (HCO3_), the excretion of hydrogen ion (H_), or both. This condition was first described in 1935, confirmed as a renal tubular disorder in 1946, and designated "renal tubular acidosis" in 1951. The RTA syndromes are characterized by a relatively normal GFR and a metabolic acidosis accompanied by hyperchloremia and a normal plasma anion gap.
RTA is classified into 4 major forms: distal, proximal, hyperkalemic and combined RTA. Distal RTA is associated with reduced urinary acid secretion, proximal RTA ( pRTA ) is characterized by impaired bicarbonate (HCO3_) reabsorption, hyperkalemic RTA is an acid-base disturbance generated by aldosterone deficiency or resistance and combined RTA is due to carbonic anhydrase II deficiency. Electrolyte and acid-base disturbances are key components of each disorder .
Patients with pRTA present with growth failure in the 1st yr of life. Additional symptoms can include polyuria, dehydration (from sodium loss), anorexia, vomiting, constipation, and hypotonia. Patients with primary Fanconi syndrome have additional symptoms, secondary to phosphate wasting, such as rickets. Hypokalemia and related symptoms are also restricted to cases with the Fanconi syndrome.
Distal RTA shares features with those of pRTA, including non-anion gap metabolic acidosis and growth failure; distinguishing features of distal RTA include nephrocalcinosis and hypercalciuria Combined proximal and distal RTA is a type observed as the result of inherited carbonic anhydrase II deficiency in different organs and systems.
Patients with type IV RTA can present with growth failure in the first few years of life. Polyuria and dehydration (from salt wasting) are common. Laboratory tests reveal a hyperkalemic non-anion gap metabolic acidosis. Urine may be alkaline or acidic. Elevated urinary sodium levels with inappropriately low urinary potassium levels reflect the absence of aldosterone effect .
The first step in the evaluation of a patient with suspected RTA is to confirm the presence of a normal anion gap metabolic acidosis, identify electrolyte abnormalities, assess renal function, and rule out other causes of bicarbonate loss such as diarrhea .
The mainstay of therapy in all forms of RTA is bicarbonate replacement. Patients with pRTA often require large quantities of bicarbonate, up to 20 mEq/kg/24 hr. The base requirement for distal RTAs is generally in the range of 2-4 mEq/kg/24 hr, although patients' requirements can vary. Patients with type IV RTA can require chronic treatment for hyperkalemia with sodium potassium exchange resin .
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Contact
- Name: Sally Ezzat
- Phone Number: 00+20 01001349860
- Email: sallyezzat1992@gmail.com
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Age : From 1 year to 18 year.
- Sex : Both sex male and female.
- All cases presented with hypokalemia and normal anion gap hyperchloremic metabolic acidosis with a relatively normal glomerular filteration rate.
Exclusion Criteria:
- Acute diarrhea .
- Urinary diversions.
- Post hypocapnia.
- Postobstructive diuresis.
- Interstitial nephritis.
- Active urinary tract infection.
- Intake of medications interfere with urinary acidification.
Study Plan
How is the study designed?
Design Details
- Observational Models: Case-Only
- Time Perspectives: Cross-Sectional
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
percentage of cases with newly diagnosed renal tubular acidosis
Time Frame: Baseline
|
percentage of cases presented by metabolic acidosis , failure to thrive and polyuria and diagnosed as RTA by arterial blood gases, blood anion gap, serum electrolytes, kidney function tests and urine analysis.
|
Baseline
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
percentage of cases with each type of RTA
Time Frame: Baseline
|
this is by measurement of serum K+ and urine PH. normal or low level of serum K+ with urine PH < 5,5 with proximal RTA, while normal or low level of serum K+ with urine PH > 5,5 with distal RTA.
high level of serum K+ with urine PH < 5,5 with hyperkalemic type 4 RTA, while high level of serum K+ with urine PH > 5,5 with voltage defect distal RTA
|
Baseline
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- RTA in childern
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Renal Tubule Acidosis
-
McMaster Children's HospitalUnknownEpilepsy | Metabolic Acidosis | Tubular Acidosis; RenalCanada
-
Universitaire Ziekenhuizen KU LeuvenUnknown
-
Advicenne PharmaTerminatedDistal Renal Tubular AcidosisUnited States, Canada
-
Advicenne PharmaWithdrawn
-
Hoffmann-La RocheCompletedRenal Tubular Acidosis, Distal, With Hemolytic AnemiaSerbia
-
Medical University of ViennaCompletedAcidosis, Renal Tubular
-
Albert Einstein College of MedicineCompletedChronic Kidney Disease | End-stage Renal Disease | Metabolic AcidosisUnited States
-
Tricida, Inc.CompletedMetabolic AcidosisUnited States, Bulgaria, Croatia, Georgia, Hungary, Serbia, Slovenia, Ukraine
-
University of Colorado, DenverDenver Health and Hospital AuthorityCompletedChronic Kidney Disease | Metabolic AcidosisUnited States
-
Erasmus Medical CenterCompletedChronic Kidney DiseaseNetherlands
Clinical Trials on Arterial blood gases
-
Inonu UniversityNot yet recruitingSepsis | Acute Kidney Injury
-
American University of Beirut Medical CenterCompletedAcute Respiratory Distress SyndromeLebanon
-
King Abdul Aziz Specialist HospitalCompletedAcute Respiratory Distress SyndromeSaudi Arabia
-
Kasr El Aini HospitalCompletedLiver TransplantationEgypt
-
National Cancer Institute, EgyptCompletedWeaning Failure | Successful WeaningEgypt
-
Oslo University HospitalSouth-Eastern Norway Regional Health AuthorityRecruitingLabor Pain | Hemodynamic Instability | Fetal Distress | Myocardium; Ischemic | Newborn AsphyxiaNorway
-
University Hospital, CaenCompleted
-
Minia UniversityRecruiting
-
I.M. Sechenov First Moscow State Medical UniversityRecruitingRespiratory Failure | Pneumonia, Bacterial | COVID-19 PneumoniaRussian Federation